Science & Technology
Pharmacological rejuvenation of human hematopoietic stem cells
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43HL172285-01
Award Ceiling
$300K
Award Floor
$300K
Close Date
Aug 31, 2025
Total Funding
$300K
Expected Awards
1
Posted Date
Sep 23, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R43HL172285-01
Description
SBIR Phase Phase I award: "Pharmacological rejuvenation of human hematopoietic stem cells" awarded to MOGLING BIO INC in CINCINNATI, Ohio. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $299,781. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.